Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease — Ying X. Gue (2022) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease
Shared by
Professor Gregory Lip
University of Liverpool
Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease
Letter
2022
en
Authors
YG
Ying X. Gue
DG
Diana A. Gorog
Professor Gregory Lip
University of Liverpool
Abstract
1 min read
© 2022 American Medical Association. All Rights Reserved. This is the accepted manuscript version of an article which has been published in final form at https://doi.org/10.1001/jamacardio.2022.1572
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Letter
2022
Factor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients?
Ying X. Gue
,
Diana A. Gorog
,
Professor Gregory Lip
Article
2021
Rural schools as effective hubs for agricultural technology dissemination: experimental evidence from Tanzania and Uganda
Henry Musa Kpaka
,
Tesfamicheal Wossen
,
Dan Joseph Stein
,
Kiddo Mtunda
,
Lembris Laizer
,
Shiferaw Feleke
,
Victor M. Manyong
Article
2009
Response to “Unsupported Claims of Ultrafast Charging of Li-ion Batteries”
Gerbrand Ceder
,
Byoungwoo Kang
Article
2020
Pupillary and Attentional Responses to Infant Facial Expressions in Mothers Across Socioeconomic Variations
Santeri Yrttiaho
,
Belinda Bruwer
,
Heather J. Zar
,
Kirsten A. Donald
,
Susan Malcolm‐Smith
,
Lee Ginton
,
Nadia Hoffman
,
Eileen Vuong
,
Dana Niehaus
,
Jukka Leppänen
,
Dan Joseph Stein
Article
2005
Obesity and the Risk of New-Onset Atrial Fibrillation—Reply
Thomas J. Wang
,
Helen Parise
,
Lisa Sullivan
,
Ralph B. D’Agostino
,
Daniel Levy
,
Philip A. Wolf
,
Ramachandran S. Vasan
,
Emelia Benjamin
Discussion(0)
No comments yet. Be the first to comment.